We have investigated the possibility of obtaining integration and expression of a native human gene in transgenic mice. An li-kilobase (kb) human chromosomal DNA fragment including the insulin gene (1430 base pairs) was microinjected into fertilized mouse eggs. This fragment was present in the genomic DNA ofseveral developing animals. One transgenic mouse and its progeny were analyzed for expression of the foreign gene. Synthesis and release of human insulin was revealed by detection ofthe human C-peptide in the plasma and urine. Human insulin mRNA was found in pancreas but not in other tissues. These findings indicate that (a) the 11-kb human DNA fragment carries the sequences necessary for tissuespecific expression of the insulin gene and (it) the human regulatory sequences react to homologous signals in the mouse.
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An accurate method to test the role and tissue specificity of putative regulatory DNA sequences is to introduce them into the germ cell line, so that they are present during development, and observing their expression in various tissues at various steps of differentiation. In the past few years, an increasing number of experiments using gene microinjection into fertilized mouse eggs have shown in the resulting transgenic mice a tissue-specific expression of the nucleotide sequences that have been introduced, independent of their site of integration in the chromosomes (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) . This suggests that specific nucleotide sequences present either in the gene itself or very close to it interact with regulatory molecules present in the differentiated tissues. These experiments, however, have been conducted mainly with rearranged mouse immunoglobulin genes (1) (2) (3) (4) (5) (6) or with composite genes involving regulatory parts of mouse or rat genes (7) (8) (9) (10) (11) (12) , in which controlling elements not yet identified could have been deleted or displaced. In a few instances, unmodified genes from mouse (13, 14) , rat (15, 16) , or chicken (17) were correctly expressed in transgenic mice, but up to very recently (18) no instance of transgenic mice expressing a human gene was reported. Also, attempts to obtain expression of the human growth hormone gene failed (19, 20) .
The insulin gene was chosen because its product, a key hormone in metabolic homeostasis, is highly conserved in animal species. Its phenotypic activity is very stringently controlled. Furthermore, its transcriptional and translational products can be differentiated from the mouse products without modification of the gene. We show that, upon its introduction into fertilized mouse eggs, the human insulin gene can be correctly expressed in transgenic mice.
MATERIALS AND METHODS
Preparation of the Human Insulin Gene for Microinjection. A HindIII DNA fragment 11 kilobases (kb) long and containing the human insulin gene [1430 base pairs (bp)] was excised from a recombinant plasmid (pBR322.Hinsll) and purified by centrifugation through a sucrose gradient. The plasmid pBR322.Hinsll was itself derived from phage X Ch4.gH1 14.1 (21) . Digestion of human placenta DNA by the restriction enzyme HindIII generates an 11-kb DNA fragment that hybridizes with the fragment prepared from pBR322.Hinsll. For microinjection, dilutions of the purified fragment were made to obtain either 400 or 40 copies per pl.
Production of Transgenic Mice. The day after mating either (C57BL/6 x CBA/He)Fl or (C57BL/6 x SJL/J)F1 mice, F2
fertilized eggs were isolated from oviducts, freed from follicle cells by hyaluronidase treatment, transferred to micromanipulation chambers, and microinjected by following the procedure described by Gordon and Ruddle (22) . About 1 pl of the DNA solution was microinjected into the male pronuclei. When microinjections were completed, the eggs were transferred to the oviducts of pseudopregnant mice. DNA Analysis. DNA was prepared as described (23) , from whole fetuses at day 13, from tail biopsy samples from 2-to 4-week-old mice, or from tissues. The presence of the human gene was checked by a dot-blot assay using 10 ,ug of DNA. DNA samples from animals that were positive were further analyzed by digestion with the restriction enzyme Bgl II; the digests were separated on 0.8% agarose slab gels by horizontal electrophoresis at 1.5 V/cm for 16-18 hr. DNA was denatured in situ and transferred to nitrocellulose paper (24 NaCl/1.5 mM sodium citrate at 650C), and exposed to x-ray film. Under the conditions of stringency used, no hybridization to endogenous sequences was observed.
RNA Analysis. RNA was prepared from mouse tissues by the guanidium thiocyanate procedure (26) , denatured by glyoxal and dimethyl sulfoxide (27) , and purified on 1% agarose slab gels by horizontal electrophoresis at 6 V/cm for 3 hr. RNA was transferred to GeneScreen membranes (New England Nuclear). The human-insulin cDNA (28) probe used was a Pvu II-Pst I 158-bp fragment including the last 21 coding bp, the 76 bp corresponding to the 3' nontranslated RNA, 45 bp of poly(A)-poly(T), and 16 
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Developmental Biology: Bucchini et al. hybridized to human pancreas total RNA and poly(A)I RNA (the latter kindly provided by J. C. Dagorn).
Determination of Human C-Peptide, Insulin, and Glucose Levels. The human C-peptide (the fragment excised from proinsulin during insulin biosynthesis) was determined by a radioimmunoassay (29) 9 dopregnant females. Since previous attempts to obtain transgenic mice with the human insulin gene were negative (30) , in a first series of experiments pregnancy was interrupted at day 13, and DNA was prepared from whole fetuses. The presence of the human gene was checked by a dot-blot assay using the 11-kb 32P-labeled DNA fragment as a probe. Southern blot analysis confirmed the positive results and showed the presence of multiple copies of the intact 11-kb fragment. In subsequent experiments, development of the mice was allowed to proceed normally. DNA prepared from tissues or tail biopsy samples was analyzed as described above for fetuses. All the positive mice also had intact copies of the gene (Fig. lA) . Of a total of 2807 eggs microinjected, 2104 were transferred into pseudopregnant females, and 13 transgenic animals (6 fetuses and 7 pups) were found among the 200 microinjected eggs that developed. Six transgenic newborns died within 24 hr, but negative littermates also died, suggesting that the death of transgenic mice was not related to the presence of the human insulin gene. ( (Fig. 1B) . This suggests that multiple copies of the 11-kb human chromosomal DNA fragment were tandemly integrated head to tail, likely at two different loci. Also, in some mice, there was a band larger than 11 kb. There is a striking difference in the total numbers of copies in Tg74 Go and Tg74.7 G, mice, on one hand, and in Tg74.4, Tg74.30, and Tg74.34 G, mice, on the other hand (Fig. 1B) .
Tg74 Mice Secrete Human Insulin. Tg74 mice had plasma levels of glucose (mean ± SD = 1.09 + 0.15 mg/ml, n = 6) and of insulin (0.81 ± 0.10 ng/ml, n = 8) similar to those of control mice (glucose = 1.12 ± 0.31 mg/ml, n = 7; and insulin = 0.76 ± 0.07 ng/ml, n = 7).
To test for gene expression, we looked for the presence of human insulin. Insulin is synthesized in pancreatic B cells as preproinsulin, which is translocated as proinsulin to the endoplasmic reticulum; proinsulin is cleaved into mature insulin and the C-peptide, which are secreted into the blood stream in equimolar quantities. Human and mouse insulin cannot be differentiated by antibodies against insulin. Therefore, we assayed for the human C-peptide because it is well known (31) that there is a high divergence between animal species, and it was likely that specific antibodies could discriminate between the human and mouse C-peptides. Discrimination was achieved by using a highly sensitive radioimmunoassay (29) with an anti-human C-peptide antiserum. Plasma and urine from control mice and littermates ofTg74 G, mice were negative. Transgenic mice had plasma levels ofhuman C-peptide ranging between 60 and 170 pg/ml. As expected (32) , their urine contained concentrations of human C-peptide 5-15 times higher (Table 1 ). This clearly indicates that the human insulin gene is expressed in Tg74 mice.
If the human insulin gene is expressed in pancreatic B cells of transgenic mice, there should be an increase in circulating hormone upon challenge with glucose. Six G1 transgenic mice were each injected intraperitoneally with 20 mg of glucose. The resulting elevation of the plasma glucose level is accompanied by an increase in circulating human C-peptide (Fig. 2) .
Presence of Human Insulin Gene Transcripts in Pancreas of Tg74 Mice. Correct phenotypic expression of the human insulin gene was further demonstrated by the presence of human insulin gene transcripts in total RNA from pancreas and their absence from other tissues. The transcripts found in total RNA prepared from pancreas of the two Tg74 G1 mice that were analyzed (Fig. 3A, lanes 4 and 5) have the size of the transcripts found in poly(A)+ RNA prepared from human pancreas (Fig. 3A lane 6 and 3B lane 1). Human insulin mRNA was specifically discriminated from mouse insulin mRNA by using a cDNA probe corresponding mainly to the 3' nontranslated human mRNA, which does not form stable hybrids with mouse insulin mRNA under stringent conditions (Fig. 3A lane 3 and 3B lane 8) . This indicates (since there is no apparent size difference between the human mRNA made in mouse and human) that the transcript initiates at or near the correct site. No hybridization to the probe was obtained with total RNAs from the other organs that were tested [liver, G, Tg74-3   Tg74-5  Tg74-11  Tg74-12  Tg74-13  Tg74-14  Tg74-15  Tg74-16  Tg74-26  Tg74-31  Tg74-32  Tg74-33  Tg74-35  Tg74-36   G2 Tg74-2-1  Tg74-2-2  Tg74-2 Fig. 2 ).
kidney, testis, submaxillary salivary glands, and heart ( Fig.  3) and muscle, brain, ovary, lung, thymus, and spleen (results not illustrated)].
All together, these data suggest that the human insulin gene is specifically expressed in pancreatic B cells of Tg74 mice and that both the transcript and the protein are normally processed.
DISCUSSION
Various genes have already been introduced into the mouse genome, and specific expression in the corresponding specialized tissues has been found (1) (2) (3) (4) (5) (6) (13) (14) (15) (16) (17) (18) . Attempts to obtain transgenic mice with the human insulin gene were restricted to the finding of two transgenic fetuses that have integrated the insulin gene linked to the pBR322 vector (33) and one transgenic mouse that did not transmit the human insulin sequence to any of its 10 offspring (30) . Expression has been reported only with composite genes including the upstream region of the rat insulin gene and the sequences coding for the large tumor antigen of simian virus 40 (11) . Contrary to what was the case with the other genes (1-6, 13-18) and because of its major role in metabolic regulation, expression of the microinjected insulin gene could have deleterious effects during intrauterine development, after birth, or both. We show that transgenic mice expressing the human insulin gene can be obtained. The demonstration is supported by the existence of a signal when pancreatic RNA is hybridized to a specific human insulin cDNA probe and by the increase of the plasma human C-peptide in response to glucose administration to transgenic mice. It was not possible to measure the mouse C-peptide, but the relative level of expression of the human insulin gene can be indirectly estimated. The plasma human C-peptide concentration in transgenic mice is 5-20% of that found in humans (32) , and the plasma insulin concentrations in transgenic mice are similar to those of control mice (our results) and of humans (34) . All together, these facts suggest that the order of magnitude of the human insulin secretion in Tg74 mice is 10% of the total insulin secretion.
All the transgenic mice that were tested produced the human C-peptide (not shown). However, Southern blot ( Fig.  1 ) and dot-blot (not shown) analysis on 42 G1 mice showed a distribution into two groups. Mice in the first group had about 50 copies of the human chromosomal DNA fragment, and those in the second had about 5 copies. This is compatible with the existence of two loci of recombination in the Tg74 Go mouse and their segregation in the progeny.
Our results indicate that the expression of intact human gene with its own controlling elements incorporated into transgenic mice can be expressed, as it was recently reported for the human f3globin gene (18) . It appears that the human regulatory sequences present in the inserted DNA fragment correctly respond to the corresponding heterospecific signals in the mouse, and one can assume that the regulatory factors involved are conserved between mouse and human. The target nucleotide sequences for these factors may display a higher degree of homology than the surrounding nonregulating sequences. Transient expression experiments with cell cultures in which the chloramphenicol acetyltransferase gene linked to the 5'-flanking region of the human insulin gene was preferentially expressed when introduced into simian virus 40-transformed hamster pancreatic 8 cells (35) suggested that some tissue-specific regulatory DNA sequences are located within the 300 bp upstream of the initiation site of transcription. Comparison of the DNA fragments, particularly on the 5' side of the insulin gene, should reveal the nucleotide sequences that are common and facilitate their isolation and the characterization of their role.
